title: [Five year survival for lung cancer patients managed in general hospitals].
abstract: BACKGROUND
  In 2000 the College of Pulmonologists of General Hospitals undertook an epidemiological study (KBP-2000-CPHG) enrolling all new cases of histologically confirmed lung cancer managed in general hospitals. This paper reports the five year survival in these cases.
  
  
  METHODS
  Vital status was available for 5447 out of 5667 patients included in the original study. The effect of different prognostic factors on mortality was assessed.
  
  
  RESULTS
  At 5 years 567 patients (10.4%) were still alive. Median survival for the 4880 (89.6%) deceased patients was 7 months. Univariate analysis identified age, smoking history, performance status, histological type and disease stage (TMN classification) as determinants of survival. For non-small cell lung cancer (n=4885) multivariate analysis identified five predictive factors for mortality - age, gender histological type, performance status and stage.
  
  
  CONCLUSIONS
  Five year survival in lung cancer continues to be poor. As the risk factors for poor outcome at the time of diagnosis are not modifiable and pending the results of screening studies reduction in mortality must rest on primary prevention.
authors.affiliation: Service de Pneumologie, Hôpital de Meaux, France.
authors.forename: M
authors.initials: M
authors.lastname: Grivaux
authors.forename: M
authors.initials: M
authors.lastname: Zureik
authors.forename: L
authors.initials: L
authors.lastname: Marsal
authors.forename: B
authors.initials: B
authors.lastname: Asselain
authors.forename: M
authors.initials: M
authors.lastname: Peureux
authors.forename: J-M
authors.initials: JM
authors.lastname: Chavaillon
authors.forename: A
authors.initials: A
authors.lastname: Prud'homme
authors.forename: M
authors.initials: M
authors.lastname: Carbonnelle
authors.forename: E
authors.initials: E
authors.lastname: Goarant
authors.forename: B
authors.initials: B
authors.lastname: Maury
authors.forename: A
authors.initials: A
authors.lastname: Bedossa
authors.forename: F
authors.initials: F
authors.lastname: Blanchon
mesh_terms: D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality* / Q000473:pathology; D018288:Carcinoma, Small Cell / Q000401:mortality* / Q000473:pathology; D003627:Data Interpretation, Statistical; D005260:Female; D005500:Follow-Up Studies; D005602:France; D006769:Hospitals, General; D006801:Humans; D053208:Kaplan-Meier Estimate; D008168:Lung / Q000473:pathology; D008175:Lung Neoplasms / Q000401:mortality* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012959:Socioeconomic Factors; D016019:Survival Analysis; D013997:Time Factors